[nanoPost] Nanoparticle Diagnostics

Company Australia

A major issue for healthcare professionals lies in the ability to detect disease states at an early stage of development.  Nano-enabled imaging and diagnostic technologies will provide:

- Rapid, cost-effective point-of-care diagnostics for animal and human health

- High-throughput sample screening thereby reducing sample size, time and cost of analysis

- Detection of CVD, neurological disorders and cancer at a much earlier stage of development than currently achievable.
 

Nanoparticle Diagnostics     

This technology aims to produce a fast, more cost-effective detection method for Meningococcal disease and sheep lice by applying nanoparticle technology to provide a rapid colour-based readout.

The technology exploits the surface plasmon resonance effects of gold nanoparticulate surfaces providing a diagnostic platform which avoids lengthy bacterial culturing and sample preparation currently required.

The market for rapid, specific and deployable diagnostics is rapidly expanding as community demands for health care grow and pressures on the health care budget increase. Selective detection on either nanoparticle or planar platforms offers a significant cost effective opportunity to develop products for the diagnosis of both pathogenic and genetic diseases. 
 

Access the contact details for this post by subscribing to premium content membership. For more details on premium content membership see our membership and fees page >> or contact info@nanoposts.com.